TRAW stock

Traws Pharma Inc (TRAW) financials · $12.1M cap

Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT

Traws Pharma Inc (TRAW) $12.1M cap.

Cached income statement (latest stored periods)
LineQ2 2026Q1 2026
Operating Income-$3.17M-$6.95M
Net Income-$3.05M-$7.11M
EPS (Diluted)-$0.16-$0.53
Cached balance sheet (latest stored periods)
LineQ2 2026Q1 2026
Total Assets$11.5M$8.16M
Current Assets$9.02M$5.67M
PP&E$5.00K$6.00K
Total Liabilities$9.78M$13.5M
Current Liabilities$9.73M$13.2M
Shareholders' Equity$1.69M-$5.31M
Retained Earnings-$650.1M-$647.1M
Cached annual cash flow
LineFY2025FY2024
Operating Cash Flow-$18.2M-$29.8M
CapEx$2.58M$3.65M
Investing Cash Flow-$2.58M-$3.65M
Financing Cash Flow$3.20M$34.0M
Net Change in Cash-$17.5M$517.0K
Free Cash Flow-$20.8M-$33.4M
These statements as JSON? API free 100/day

FAQ

What is TRAW P/E and revenue?

Traws Pharma Inc (TRAW) $12.1M cap.

What is TRAW revenue?

TRAW income-statement cache has no revenue figure yet.

Is TRAW profitable?

Traws Pharma Inc last cached net income is -$3.05M (Q2 2026).

What are TRAW total assets?

Traws Pharma Inc last cached total assets are $11.5M (Q2 2026).

What is TRAW free cash flow?

Traws Pharma Inc last cached free cash flow is -$20.8M (FY2025).

Not investment advice. Cached statements, not a live tape.